Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OrbiMed Closes $550 Million Fund

Mar 01 2010

• By Alex Lash

Related Content

Biopharma Trends: Nowhere To Go But Up

Jan 01 2010

Biotech Backers Are Learning to Live with Exit-by-Earn-out

Mar 01 2010

2009's Private Biotech Acquisitions Are a Tale of Two Step-Ups

Jan 01 2010

Tighter FDA Review Squeezing Device VCs

Dec 01 2009

Related Companies

BioCryst Pharmaceuticals, Inc.

Sanofi Genzyme

Bioenvision

Human Genome Sciences, Inc.

Dendreon Corporation

Vertex Pharmaceuticals Incorporated

Astellas Pharma, Inc.

Additional Topics

Business Strategies BioPharmaceutical Medical Device

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window